KIT-pharma

KIT-PHARMA is a pharmacy chain in the Moscow region. It is represented by pharmacies in Balashikha, Reutov and Lyubertsy.

History

2022: Pharmacy chain "36.6" bought "Kit-Pharma"

In early September 2022, it became known about the sale of Keith Pharma the "pharmacy chain 36,6." 29 pharmacies entered the deal perimeter. General Director DSM Group Sergei Shulyak estimates the value of the transaction at 150-180 million. rubles

According to Kommersant, the deal to sell the business to the structures of Pharmacy-A.V.E and Pharmacy-A.V.E-1 was closed at the end of August 2022.

Pharmacy chain "36.6" bought "Kit-Pharma"

The former owner of Kit-Pharma, Vasily Kupreev, told the newspaper that he would not manage pharmacies after their transfer to the ownership of 36.6. The former owners of Kit-Pharma still have another business - a network of three clinics "Family Medical Center" in the Moscow region. Kupreev explained the sale of his pharmacy business by the fact that "the time has come." In January-August 2022, only a few significant transactions were concluded on the Russian pharmaceutical market. So, in particular, Ufa "Farmland" acquired 130 pharmacies "Orenlek" in the Orenburg region. And Rigla entered into an agreement on the takeover of SPAR-Pharmacy in the Tula region.

Interviewed by the market publication note that against the background of falling revenue, many small independent networks are put up for sale. The peak of demand for medicines fell on March 2022, after which the trade turnover of pharmacies began to fall. According to the results of the second quarter of 2022, for the first time in almost two years, the number of pharmacies in Russia decreased.

There have always been enough offers to buy small networks on the market, Sergei Shulyak points out. When buying small chains, large pharmaceutical retailers by optimizing, changing management decisions, assortment can achieve an increase in the profitability of purchased points, the expert explains. Potential buyers are now very careful, since buying is always a risk, and in the current conditions also with not fully clear prospects, Bespalov agrees. Now, according to him, network purchases are rather isolated cases, and not a global industry strategy.^[1]

Notes

Шаблон:Remarks